PolyModels Hub raises £7m in Series A funding from Molten Ventures and Marathon Venture Capital to expand its software platform.
Molten Ventures led the Series A round with participation from Marathon Venture Capital to support team expansion and platform development.
PolyModels Hub is a biotech software company building a digital platform for biopharma process development. The firm combines advanced modelling and workflow management to help pharmaceutical teams design and manufacture medicines more efficiently.
PolyModels Hub has secured £7m in Series A funding led by Molten Ventures, with participation from Marathon Venture Capital. The company provides a unified platform for pharmaceutical teams to manage modelling, simulation, and workflow tasks. The capital will be deployed to expand engineering and product teams, enhance the core software, and scale operations globally.
From the founder
"The pharmaceutical industry is undergoing a once-in-a-generation digital transformation. In just 18 months, our technology and exceptional team have delivered tangible value to major pharma partners across multiple blockbuster programs, expanding these collaborations to a truly global scale. I’m incredibly excited about the road ahead — and about welcoming Molten Ventures as a partner on this journey."
Antonio Benedetti
Co-Founder and CEO at PolyModels Hub
Investor perspective
"What impressed us most is the PolyModels Hub team’s blend of technical know-how and deep understanding of its customers’ real-world challenges. They’ve built a solution that delivers value in weeks, not years, and its rapid adoption by major pharma companies speaks volumes."
Ben Wilkinson
CEO, Molten Ventures
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
Investors
Categories
About the company
PolyModels Hub
PolyModels Hub builds a digital platform for biopharma process development and manufacturing.